Back to search results

A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

Abroad (travel likely)RecruitingPHASE3

Conditions

Juvenile Psoriatic Arthritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Arkansas Children's Hospital /ID# 258776, Little Rock, Arkansas, United States

    Study coordinator · 501-364-3686

  • Childrens National Medical Center /ID# 259284, Washington D.C., District of Columbia, United States

    Study coordinator · qyu@childrensnational.org

  • Joe Dimaggio Children's Hospital Hollywood /ID# 260634, Hollywood, Florida, United States

    Study coordinator · 954-265-4466

  • All X Ray Diagnostic Services Corp /ID# 278523, Miami, Florida, United States

    Study coordinator · thalialopez@allxray.com · (305) 445-9462

  • Indiana University Health Riley Hospital for Children /ID# 259067, Indianapolis, Indiana, United States

  • M Health Fairview University of Minnesota Medical Center - West Bank /ID# 260111, Minneapolis, Minnesota, United States

    Study coordinator · rheum-research@umn.edu

  • Columbia University Medical Center /ID# 262587, New York, New York, United States

    Study coordinator · 212-305-4308

  • Boston Childrens Health Physicians /ID# 258061, Valhalla, New York, United States

    Study coordinator · 914-504-0152

  • University of North Carolina - Children's Hospital /ID# 259286, Chapel Hill, North Carolina, United States

    Study coordinator · 919-504-6650

  • MetroHealth Medical Center /ID# 262377, Cleveland, Ohio, United States

  • Child Neurology Consultants of Austin /ID# 260562, Austin, Texas, United States

    Study coordinator · 512-494-4000

  • Monash Health - Monash Medical Centre - Clayton /ID# 260255, Clayton, Victoria, Australia

  • Alberta Children's Hospital /ID# 257880, Calgary, Alberta, Canada

  • British Columbia Children and Women's Hospital and Health Centre /ID# 257884, Vancouver, British Columbia, Canada

  • Hospital for Sick Children /ID# 257879, Toronto, Ontario, Canada

  • CHU Bordeaux - Hopital Pellegrin /ID# 258729, Bordeaux, New Aquitaine, France

  • AP-HP - Hopital Bicetre /ID# 258728, Le Kremlin-Bicêtre, Paris, France

  • Asklepios Klinik Sankt Augustin /ID# 259106, Sankt Augustin, North Rhine-Westphalia, Germany

    Study coordinator · +49-2241-249-240

  • Helios Klinikum Berlin - Buch /ID# 268803, Berlin, Germany

    Study coordinator · kinderklinik.berlin-buch@helios-gesundheit.de

  • Hamburger Zentrum fuer Kinder- und Jugendrheumatologie /ID# 259104, Hamburg, Germany

  • Azienda Ospedaliero Universitaria Meyer /ID# 258587, Florence, Firenze, Italy

  • ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO /ID# 276753, Milan, Milano, Italy

  • Ospedale Pediatrico Bambino Gesù /ID# 258869, Rome, Roma, Italy

  • Malopolskie Badania Kliniczne /ID# 258777, Cracow, Lesser Poland Voivodeship, Poland

  • Uniwersytecki Szpital Dzieciecy w Lublinie /ID# 258781, Lublin, Lublin Voivodeship, Poland

  • Narodowy Instytut Geriatrii, Reumatologii I Rehabilitacji /ID# 277050, Warsaw, Masovian Voivodeship, Poland

  • Centrum Zdrowia Dziecka i Rodziny im Jana Pawla II w Sosnowcu /ID# 277058, Sosnowiec, Silesian Voivodeship, Poland

  • SPZOZ Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi /ID# 258785, Lodz, Łódź Voivodeship, Poland

  • Hospital Sant Joan de Deu /ID# 257568, Esplugues de Llobregat, Barcelona, Spain

  • Hospital Universitario y Politecnico La Fe /ID# 257567, Valencia, Spain

  • Sheffield Children's Hospital NHS Foundation Trust /ID# 258848, Sheffield, England, United Kingdom

  • University Hospitals Bristol and Weston NHS Foundation Trust /ID# 258847, Bristol, United Kingdom

  • Alder Hey Children's NHS Foundation Trust /ID# 262770, Liverpool, United Kingdom

Study leads

  • ABBVIE INC.

    Study Director

    AbbVie

View source on ClinicalTrials.gov(opens in a new tab)